ArticleBMJ open2026

Multicentre, 2×2 factorial, randomised, open-label trial of neuromodulators and cough control therapy for refractory or unexplained chronic cough: the FORTITUDE trial protocol.

Elena Kum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.